Zoetis plans cautiously for 2027 as pet owners cut vet visits

Animal-health company Zoetis is planning cautiously for 2027 as pet owners cut back on veterinary visits. That puts continued weakness in pet healthcare demand among the risks shaping its business plans.^[1]

In its third-quarter 2026 results released on November 5, Zoetis said growth in livestock and diagnostics partially offset continuing pressure in its companion-animal business, which serves pets. The company narrowed its full-year 2026 revenue guidance range and raised its adjusted earnings-per-share guidance—its forecast of profit per share using the company's adjustments.^[2]

When owners make fewer appointments, clinics have fewer opportunities to earn consultation fees, diagnose conditions, prescribe medicines and start treatment. That can travel back through the purchasing chain: if clinics use and sell fewer medicines, they may order less from Zoetis and competing suppliers, putting pressure on pet-medicine sales growth.^[1]

The mix of businesses therefore matters. Zoetis says livestock and diagnostics growth cushioned some of the pressure in pet healthcare. For animal-health companies with several business lines, those other revenue sources can soften the impact of fewer pet visits, with the protection depending on each business's size and growth.^[2]

Impact